VetStem Biopharma proudly announces former owner of Cave Creek Equine Surgical and Diagnostic Imaging Center, Ross Rich DVM, PA-C, as Director of Clinical Development.
Advancing regenerative medicine for equines
Dr. Rich treated over 600 patients using the VetStem procedure and presented three single center studies for horses treated with the VetStem therapy over the last 3 years.
© Shutterstock
âWith over 25 years of experience in the equine market and having extensive hands on experience in the regenerative medicine field Dr. Rich will be a great addition to our veterinarian led organization,â Dr. Alexis Nahama, President and Chief Commercial Officer, explains.
âDr. Rich will be responsible for the continued development of new services, products and clinical data generation for both our small animal and equine clients. We believe his rigorous military background; his extensive knowledge of regenerative medicine and his hands on experience over the last 10 years gives Dr Rich a unique perspective on what new products and services will be most valuable to our clients.â
Dr. Rich is an ISELP trained lameness and diagnostic imaging specialist, and an expert in the treatment of orthopedic injuries with Regenerative Medicine. Dr. Rich treated over 600 patients using the VetStem procedure and presented three single center studies for horses treated with the VetStem therapy over the last 3 years.
âI am so excited to join the VetStem team, and to have the opportunity to help bring regenerative medicine to the forefront of medical therapy and FDA approval. During the past 11 years, while implementing stem cell therapy in my equine sports medicine and surgical practice, I was constantly amazed at the tendon, ligament, bone, and joint injuries that I was now able to fix using regenerative medicine, that I could never fix before."
"Not only could we now repair these injuries with VetStemâs adipose-derived stem cells, but the convalescent time was dramatically shortened, and re-injury rates dramatically reduced when the horses returned to competition."
"This provided huge financial savings for the owners, as well as a reduction in their emotional distress, when you take into account all of the costs of maintaining a horse during the rehab period, the time lost from competition, and the significant reduction in re-injury rates after returning to competition.
About VetStem Biopharma.
VetStem Biopharma is a veterinarian led company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patientsâ own fat tissue) among other regenerative modalities.
With a unique expertise acquired over the past 12 years and 10,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures.
The companyâs stated mission being âto extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseasesâ. In addition to itsâ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.